Search Results - "Stimpel, M"

Refine Results
  1. 1

    Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro by Hatton, R, Stimpel, M, Chambers, T J

    Published in Journal of endocrinology (01-01-1997)
    “…During bone resorption, osteoclasts are closely associated with endothelial cells. The latter are able to produce several agents that regulate bone resorption…”
    Get more information
    Journal Article
  2. 2
  3. 3
  4. 4

    Impact of antihypertensive therapy on the skeleton: effects of moexipril and hydrochlorothiazide on osteopenia in spontaneously hypertensive ovariectomized rats by MA, Y. F, STIMPEL, M, LIANG, H, PUN, S, JEE, W. S. S

    Published in Journal of endocrinology (01-09-1997)
    “…Skeletal effects of moexipril, an angiotensin-converting enzyme (ACE) inhibitor, and hydrochlorothiazide (HCTZ), a thiazide diuretic, were studied in…”
    Get full text
    Journal Article
  5. 5

    Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients by PERSSON, B, STIMPEL, M

    “…To compare the antihypertensive efficacy of moexipril, a new angiotensin-converting enzyme (ACE) inhibitor, to treatment with hydrochlorothiazide (HCTZ). Two…”
    Get full text
    Journal Article
  6. 6

    Antihypertensive treatment with moexipril plus HCTZ vs metoprolol plus HCTZ in patients with mild-to-moderate hypertension by STIMPEL, M, KOCH, B

    Published in Journal of human hypertension (01-02-1997)
    “…Combination therapy with the new ACE inhibitor moexipril plus hydrochlorothiazide (HCTZ) results in significant blood pressure (BP) reductions. This study…”
    Get full text
    Journal Article
  7. 7

    Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension by AGABITI-ROSEI, E, AMBROSIONI, E, PIRELLI, A, STIMPEL, M, ZANCHETTI, A

    Published in European journal of clinical pharmacology (01-05-1999)
    “…Objective: The aim of this study was to compare the efficacy and tolerability of the new angiotensin-converting enzyme (ACE) inhibitor moexipril and the…”
    Get full text
    Conference Proceeding Journal Article
  8. 8
  9. 9

    Effects of moexiprilat on oestrogen‐stimulated cardiac fibroblast growth by Grohé, C, Kahlert, S, Löbbert, K, Eickels, M, Stimpel, M, Vetter, H, Neyses, L

    Published in British journal of pharmacology (01-08-1997)
    “…The effects of 2‐2‐(1‐(ethoxycarbonyl)‐3‐phenylpropyl)‐[amino‐oxopropyl]−6,7‐dimethoxy‐1,2,3,4‐tetrahydroisoquinoline‐3 carboxylic acid (moexiprilat),…”
    Get full text
    Journal Article
  10. 10

    Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpurea by STIMPEL, M, PROKSCH, A, WAGNER, H, LOHMANN-MATTHES, M.-L

    Published in Infection and Immunity (01-12-1984)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  11. 11

    Comparison between moexipril and atenolol in obese postmenopausal women with hypertension by Stimpel, M., Koch, B., Weber, M.A.

    Published in Maturitas (20-09-1998)
    “…The present study investigated the effect of the new ACE-inhibitor moexipril versus the β 1-adrenergic blocker atenolol on metabolic parameters, adverse events…”
    Get full text
    Journal Article
  12. 12

    Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension by White, W B, Stimpel, M

    Published in Journal of human hypertension (01-11-1995)
    “…The purpose of this study was to evaluate the long-term safety and efficacy of moexipril, a non-sulphydryl angiotensin converting enzyme inhibitor, alone or in…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Long-term efficacy and safety of moexipril in the treatment of hypertension by White, W B, Fox, A A, Stimpel, M

    Published in Journal of human hypertension (01-12-1994)
    “…The purpose of this study was to assess the long-term efficacy and safety of moexipril, a new angiotensin-converting enzyme inhibitor, alone or in combination…”
    Get more information
    Journal Article
  15. 15

    Antihypertensive effects of moexipril, a new ACE inhibitor, as add-on therapy to nifedipine in patients with essential hypertension by Persson, B, Widgren, B R, Fox, A, Stimpel, M

    Published in Journal of cardiovascular pharmacology (01-07-1995)
    “…Moexipril is a new nonpeptide angiotensin-converting enzyme (ACE) inhibitor with an intermediate duration of action. The antihypertensive efficacy and safety…”
    Get more information
    Journal Article
  16. 16

    Comparison of the efficacy of three dose levels of moexipril versus placebo as add-on therapy to hydrochlorothiazide in patients with moderate hypertension by Dickstein, K, Aarsland, T, Ferrari, P, Todd, M, Stimpel, M

    Published in Journal of cardiovascular pharmacology (01-08-1994)
    “…This parallel, double-blind trial was designed to evaluate the efficacy of three dose levels of moexipril versus placebo as add-on therapy to…”
    Get more information
    Journal Article
  17. 17

    Stereospecific modulation of the calcium channel in human erythrocytes by cholesterol and its oxidized derivatives by Neyses, L, Locher, R, Stimpel, M, Streuli, R, Vetter, W

    Published in Biochemical journal (01-04-1985)
    “…To study the effect of cholesterol and its pathophysiologically important oxidized derivatives (OSC) on the calcium entry channel, the human red blood cell was…”
    Get full text
    Journal Article
  18. 18

    Cardiac myocytes and fibroblasts contain functional estrogen receptors by Grohé, Christian, Kahlert, Stefan, Löbbert, Kerstin, Stimpel, Michael, Karas, Richard H., Vetter, Hans, Neyses, Ludwig

    Published in FEBS letters (13-10-1997)
    “…Gender-based differences found in cardiovascular diseases raise the possibility that estrogen may have direct effects on cardiac tissue. Therefore we…”
    Get full text
    Journal Article
  19. 19

    17 beta -Estradiol Prevents Programmed Cell Death in Cardiac Myocytes by Pelzer, T, Schumann, M, Neumann, M, Dejager, T, Stimpel, M, Serfling, E, Neyses, L

    “…The cardioprotective effects of estrogens are clearly established. However, the underlying mechanisms are poorly understood. Because programmed cell death…”
    Get full text
    Journal Article
  20. 20

    Are calcium antagonists helpful in the management of primary aldosteronism? by Stimpel, M, Ivens, K, Wambach, G, Kaufmann, W

    “…The chronic effect of the calcium antagonist nitrendipine, a 1,4-dihydropyridine derivative, on blood pressure (BP), plasma aldosterone concentration (PAC),…”
    Get more information
    Journal Article